Global Metastatic Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Metastatic Prostate Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Mono
  • 1.2.3 Combination
  • 1.2.4 Mono/Combination
• 1.3 Market by Application
  • 1.3.1 Global Metastatic Prostate Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospital
  • 1.3.3 Drug Store
  • 1.3.4 Online Pharmacy
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Metastatic Prostate Cancer Treatment Market Perspective (2016-2027)
• 2.2 Metastatic Prostate Cancer Treatment Growth Trends by Regions
  • 2.2.1 Metastatic Prostate Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Metastatic Prostate Cancer Treatment Historic Market Share by Regions (2016-2021)
  • 2.2.3 Metastatic Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027)
• 2.3 Metastatic Prostate Cancer Treatment Industry Dynamic
  • 2.3.1 Metastatic Prostate Cancer Treatment Market Trends
  • 2.3.2 Metastatic Prostate Cancer Treatment Market Drivers
  • 2.3.3 Metastatic Prostate Cancer Treatment Market Challenges
  • 2.3.4 Metastatic Prostate Cancer Treatment Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Metastatic Prostate Cancer Treatment Players by Revenue
  • 3.1.1 Global Top Metastatic Prostate Cancer Treatment Players by Revenue (2016-2021)
  • 3.1.2 Global Metastatic Prostate Cancer Treatment Revenue Market Share by Players (2016-2021)
• 3.2 Global Metastatic Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Metastatic Prostate Cancer Treatment Revenue
• 3.4 Global Metastatic Prostate Cancer Treatment Market Concentration Ratio
  • 3.4.1 Global Metastatic Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Metastatic Prostate Cancer Treatment Revenue in 2020
• 3.5 Metastatic Prostate Cancer Treatment Key Players Head office and Area Served
• 3.6 Key Players Metastatic Prostate Cancer Treatment Product Solution and Service
• 3.7 Date of Enter into Metastatic Prostate Cancer Treatment Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Metastatic Prostate Cancer Treatment Breakdown Data by Type

• 4.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Type (2016-2021)
• 4.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Metastatic Prostate Cancer Treatment Breakdown Data by Application

• 5.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Application (2016-2021)
• 5.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Metastatic Prostate Cancer Treatment Market Size (2016-2027)
• 6.2 North America Metastatic Prostate Cancer Treatment Market Size by Type
  • 6.2.1 North America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
  • 6.2.2 North America Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
  • 6.2.3 North America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
• 6.3 North America Metastatic Prostate Cancer Treatment Market Size by Application
  • 6.3.1 North America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
  • 6.3.2 North America Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
  • 6.3.3 North America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
• 6.4 North America Metastatic Prostate Cancer Treatment Market Size by Country
  • 6.4.1 North America Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
  • 6.4.2 North America Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Metastatic Prostate Cancer Treatment Market Size (2016-2027)
• 7.2 Europe Metastatic Prostate Cancer Treatment Market Size by Type
  • 7.2.1 Europe Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
  • 7.2.2 Europe Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
  • 7.2.3 Europe Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
• 7.3 Europe Metastatic Prostate Cancer Treatment Market Size by Application
  • 7.3.1 Europe Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
  • 7.3.2 Europe Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
  • 7.3.3 Europe Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
• 7.4 Europe Metastatic Prostate Cancer Treatment Market Size by Country
  • 7.4.1 Europe Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
  • 7.4.2 Europe Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size (2016-2027)
• 8.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type
  • 8.2.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application
  • 8.3.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region
  • 8.4.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Metastatic Prostate Cancer Treatment Market Size (2016-2027)
• 9.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Type
  • 9.2.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
  • 9.2.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
  • 9.2.3 Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
• 9.3 Latin America Metastatic Prostate Cancer Treatment Market Size by Application
  • 9.3.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
  • 9.3.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
  • 9.3.3 Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
• 9.4 Latin America Metastatic Prostate Cancer Treatment Market Size by Country
  • 9.4.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
  • 9.4.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size (2016-2027)
• 10.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type
  • 10.2.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application
  • 10.3.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country
  • 10.4.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 AB Science
  • 11.1.1 AB Science Company Details
  • 11.1.2 AB Science Business Overview
  • 11.1.3 AB Science Metastatic Prostate Cancer Treatment Introduction
  • 11.1.4 AB Science Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
  • 11.1.5 AB Science Recent Development
• 11.2 BeiGene
  • 11.2.1 BeiGene Company Details
  • 11.2.2 BeiGene Business Overview
  • 11.2.3 BeiGene Metastatic Prostate Cancer Treatment Introduction
  • 11.2.4 BeiGene Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
  • 11.2.5 BeiGene Recent Development
• 11.3 eFFECTOR Therapeutics
  • 11.3.1 eFFECTOR Therapeutics Company Details
  • 11.3.2 eFFECTOR Therapeutics Business Overview
  • 11.3.3 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Introduction
  • 11.3.4 eFFECTOR Therapeutics Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
  • 11.3.5 eFFECTOR Therapeutics Recent Development
• 11.4 Immunomedics(Gilead Sciences, Inc.)
  • 11.4.1 Immunomedics(Gilead Sciences, Inc.) Company Details
  • 11.4.2 Immunomedics(Gilead Sciences, Inc.) Business Overview
  • 11.4.3 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Introduction
  • 11.4.4 Immunomedics(Gilead Sciences, Inc.) Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
  • 11.4.5 Immunomedics(Gilead Sciences, Inc.) Recent Development
• 11.5 Myovant Biosciences
  • 11.5.1 Myovant Biosciences Company Details
  • 11.5.2 Myovant Biosciences Business Overview
  • 11.5.3 Myovant Biosciences Metastatic Prostate Cancer Treatment Introduction
  • 11.5.4 Myovant Biosciences Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
  • 11.5.5 Myovant Biosciences Recent Development
• 11.6 SeleXel
  • 11.6.1 SeleXel Company Details
  • 11.6.2 SeleXel Business Overview
  • 11.6.3 SeleXel Metastatic Prostate Cancer Treatment Introduction
  • 11.6.4 SeleXel Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
  • 11.6.5 SeleXel Recent Development
• 11.7 Zenith Epigenetics Ltd.
  • 11.7.1 Zenith Epigenetics Ltd. Company Details
  • 11.7.2 Zenith Epigenetics Ltd. Business Overview
  • 11.7.3 Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Introduction
  • 11.7.4 Zenith Epigenetics Ltd. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
  • 11.7.5 Zenith Epigenetics Ltd. Recent Development
• 11.8 VasGene Therapeutics, Inc.
  • 11.8.1 VasGene Therapeutics, Inc. Company Details
  • 11.8.2 VasGene Therapeutics, Inc. Business Overview
  • 11.8.3 VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Introduction
  • 11.8.4 VasGene Therapeutics, Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
  • 11.8.5 VasGene Therapeutics, Inc. Recent Development
• 11.9 Telix Pharmaceuticals
  • 11.9.1 Telix Pharmaceuticals Company Details
  • 11.9.2 Telix Pharmaceuticals Business Overview
  • 11.9.3 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Introduction
  • 11.9.4 Telix Pharmaceuticals Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
  • 11.9.5 Telix Pharmaceuticals Recent Development
• 11.10 Arvinas Inc.
  • 11.10.1 Arvinas Inc. Company Details
  • 11.10.2 Arvinas Inc. Business Overview
  • 11.10.3 Arvinas Inc. Metastatic Prostate Cancer Treatment Introduction
  • 11.10.4 Arvinas Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
  • 11.10.5 Arvinas Inc. Recent Development
• 11.11 Amgen
  • 11.11.1 Amgen Company Details
  • 11.11.2 Amgen Business Overview
  • 11.11.3 Amgen Metastatic Prostate Cancer Treatment Introduction
  • 11.11.4 Amgen Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
  • 11.11.5 Amgen Recent Development
• 11.12 Genentech
  • 11.12.1 Genentech Company Details
  • 11.12.2 Genentech Business Overview
  • 11.12.3 Genentech Metastatic Prostate Cancer Treatment Introduction
  • 11.12.4 Genentech Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
  • 11.12.5 Genentech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer